Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-09-18FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for UROXATRAL (alfuzosin hydrochloride) from Advanz Pharma (US) Corp., updating the existing NDA…
-
FDA approval · 2008-08-07FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for finasteride by Teva Pharmaceuticals USA, Inc., finalizing an update to an existing generic f…
-
FDA approval · 2008-08-07FDA Approved: CIALIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cialis (tadalafil) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) [Phase 4]
A Phase 4 clinical trial comparing bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia has com…
-
CLINICAL_TRIALS trial_result · 2008-06-09Clinical Trial Update: Clinical Trial in Males With BPH (Enlarged Prostate) [Phase 3]
Phase 3 clinical trial in men with benign prostatic hyperplasia has completed; the update confirms the trial status but does not disclose re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-06-05Clinical Trial Update: A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart [Phase 4]
This Phase 4 trial investigates whether switching from finasteride (Proscar) to dutasteride (Avodart) improves symptoms of benign prostatic …
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker [NA]
This completed trial investigated combining dual 5-alpha reductase inhibition with an alpha blocker to treat refractory urinary retention du…
-
FDA approval · 2008-05-06FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) from Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2008-04-25Clinical Trial Update: Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate
A clinical trial comparing Holmium Laser Ablation of the Prostate (HoLAP) with KTP laser vaporization of the prostate for benign prostatic h…
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study [Phase 4]
Phase 4 trial update on Alfuzosin XL for lower urinary tract symptoms due to prostatic disease has completed, with data on efficacy and sexu…
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Once Daily Given Alfuzosin in the Treatment of BPH [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating once-daily alfuzosin for benign prostatic hyperplasia.
-
FDA approval · 2008-03-31FDA Approved: AVODART — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Avodart (dutasteride) filed by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: A Prospective Evaluation of the GreenLight Model 120 Laser [Phase 4]
This Phase 4 clinical trial evaluated the GreenLight Model 120 Laser for treating benign prostatic hyperplasia and has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-14Clinical Trial Update: A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation [Phase 2]
A Phase 2 clinical trial investigating factors that influence the absorption and serum levels of lycopene after supplementation in individua…
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study [Phase 4]
Phase 4 study completion evaluating the Male Sexual Health Questionnaire (MSHQ) for sexual function in men with benign prostatic hyperplasia…
-
CLINICAL_TRIALS trial_result · 2007-11-27Clinical Trial Update: Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter [Phase 4]
Phase 4 trial evaluating whether dutasteride reduces the risk of acute urinary retention relapse after catheter removal in men with benign p…
-
FDA approval · 2007-10-30FDA Approved: FINASTERIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic finasteride manufactured by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2007-10-22Clinical Trial Update: Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems [Phase 2]
Phase 2 trial update describing the safety and effectiveness of tadalafil for benign prostatic hyperplasia. The study has completed.
-
CLINICAL_TRIALS trial_result · 2007-10-11Clinical Trial Update: Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy [Phase 4]
A Phase 4 multicenter prospective study evaluated changes in sexual function in men treated with alfuzosin (Xatral XL) for benign prostatic …
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study evaluating alcohol (ethanol) injection for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2007-10-08Clinical Trial Update: The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating the efficacy, onset of effect, and safety of Alfuzosin once daily for lower urinary …
-
FDA approval · 2007-10-01FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for finasteride by Teva Pharmaceuticals USA, Inc., confirming the generic product's approval under a…
-
CLINICAL_TRIALS trial_result · 2007-09-24Clinical Trial Update: ALF-STONE: Alfuzosin in Uretheric Stones [Phase 3]
Sanofi-sponsored Phase 3 trial of Alfuzosin for benign prostatic hyperplasia has been terminated.
-
CLINICAL_TRIALS research · 2007-09-05Clinical Trial Update: Early Detection of Prostate Cancer by FACS
A clinical trial update on using fluorescence-activated cell sorting (FACS) for early detection of prostate cancer; the current trial status…
-
FDA approval · 2007-08-09FDA Approved: TERAZOSIN HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
The FDA approved a supplemental application for terazosin hydrochloride from Apnar Pharma LP, confirming the generic product's approval and …